fructose-1,6-diphosphate has been researched along with Epilepsy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borges, K; McDonald, TS; Neal, ES | 1 |
| Lian, XY; Stringer, JL; Xu, K | 1 |
2 other study(ies) available for fructose-1,6-diphosphate and Epilepsy
| Article | Year |
|---|---|
Fructose 1,6-bisphosphate is anticonvulsant and improves oxidative glucose metabolism within the hippocampus and liver in the chronic pilocarpine mouse epilepsy model.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Epilepsy; Fructose; Fructosediphosphates; Glucose; Hippocampus; Liver; Mice; Oxidative Stress; Pilocarpine; Status Epilepticus | 2021 |
Oral administration of fructose-1,6-diphosphate has anticonvulsant activity.
Topics: 4-Butyrolactone; Action Potentials; Administration, Oral; Animals; Anticonvulsants; Brain; Cerebral Cortex; Convulsants; Disease Models, Animal; Epilepsy; Fructosediphosphates; Male; Pilocarpine; Rats; Rats, Sprague-Dawley; Status Epilepticus; Treatment Outcome | 2008 |